GENE ONLINE|News &
Opinion
Blog

Molnupiravir
Trials & Approvals FDA
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
COVID-19 COVID-19 Pill
Updated Trial Data Shows Lower Efficacy for Merck’s Oral COVID-19 Pill
2021-11-26
COVID-19 Molnupiravir
Singapore Becomes Latest Asian Country to Sign Merck Deal for Oral COVID-19 Pill
2021-10-06
COVID-19 Antiviral
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
COVID-19 Remdesivir
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
COVID-19 Anti-COVID Drug
Merck Says Preliminary Trial Findings of Oral COVID-19 Drug Encouraging
2021-03-08
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top